Division of Pulmonary, Critical Care, Sleep and Allergy Research

2 division members standing in front of a poster

The Division of Pulmonary, Critical Care, Sleep and Allergy members are highly engaged in advancing the science of practice of medicine with diverse areas of expertise including vascular biology, immunology, clinical outcomes and implementation research spread across pulmonary, critical care, sleep and allergy specialties. Our faculty are nationally and internationally recognized as leaders in their respective fields. The specific programs in the Division concentrate in Pulmonary Hypertension, ARDS and Lung Injury, Lung cancer, COPD and Asthma, Sleep Disorders and Nanomedicine and Drug Discovery. We have a very active portfolio of research projects, funded by the National Institutes of Health, VA system, PCORI, AHA, RHA, and various other private foundations or pharmaceutical companies.

Since 2023, the Division has experienced significant growth, with 36 newly awarded grants and over $ 17 million in direct and indirect funding from all active grants, among which 65% is from federal agencies. During this time, its members published original scholarly works supported by more than 26 independently funded investigators specializing in translational pulmonary disease research.

As a result, it has established a strong track record in securing Career Development Awards, with 12 current junior faculty members, obtaining NIH Career Development Awards or equivalent funding over the past 5 years and 2 recently advancing to independent R-level Research Awards at the department.

Research Awards/Grants